Mader, N.; Schoeler, C.; Pezeshkpour, N.; Klimek, K.; Groener, D.; Happel, C.; Tselis, N.; Mandel, P.; Grünwald, F.; Sabet, A.
Intermittent Radioligand Therapy with 177Lu-PSMA-617 for Oligometastatic Castration-Resistant Prostate Cancer. Cancers 2023, 15, 4605.
https://doi.org/10.3390/cancers15184605
AMA Style
Mader N, Schoeler C, Pezeshkpour N, Klimek K, Groener D, Happel C, Tselis N, Mandel P, Grünwald F, Sabet A.
Intermittent Radioligand Therapy with 177Lu-PSMA-617 for Oligometastatic Castration-Resistant Prostate Cancer. Cancers. 2023; 15(18):4605.
https://doi.org/10.3390/cancers15184605
Chicago/Turabian Style
Mader, Nicolai, Christina Schoeler, Niloufar Pezeshkpour, Konrad Klimek, Daniel Groener, Christian Happel, Nikolaos Tselis, Philipp Mandel, Frank Grünwald, and Amir Sabet.
2023. "Intermittent Radioligand Therapy with 177Lu-PSMA-617 for Oligometastatic Castration-Resistant Prostate Cancer" Cancers 15, no. 18: 4605.
https://doi.org/10.3390/cancers15184605
APA Style
Mader, N., Schoeler, C., Pezeshkpour, N., Klimek, K., Groener, D., Happel, C., Tselis, N., Mandel, P., Grünwald, F., & Sabet, A.
(2023). Intermittent Radioligand Therapy with 177Lu-PSMA-617 for Oligometastatic Castration-Resistant Prostate Cancer. Cancers, 15(18), 4605.
https://doi.org/10.3390/cancers15184605
